A genome‐scale CRISPR knock‐out screen in chronic myeloid leukemia identifies novel drug resistance mechanisms along with intrinsic apoptosis and MAPK signaling

MLA

Matthieu Lewis, et al. “A Genome‐scale CRISPR Knock‐out Screen in Chronic Myeloid Leukemia Identifies Novel Drug Resistance Mechanisms along with Intrinsic Apoptosis and MAPK Signaling.” Cancer Medicine, vol. 9, no. 18, Sept. 2020, pp. 6739–51. EBSCOhost, https://doi.org/10.1002/cam4.3231.

APA

Matthieu Lewis, Valérie Prouzet‐Mauléon, Florence Lichou, Elodie Richard, Richard Iggo, Béatrice Turcq, & François‐Xavier Mahon. (2020). A genome‐scale CRISPR knock‐out screen in chronic myeloid leukemia identifies novel drug resistance mechanisms along with intrinsic apoptosis and MAPK signaling. Cancer Medicine, 9(18), 6739–6751. https://doi.org/10.1002/cam4.3231

Chicago

Matthieu Lewis, Valérie Prouzet‐Mauléon, Florence Lichou, Elodie Richard, Richard Iggo, Béatrice Turcq, and François‐Xavier Mahon. 2020. “A Genome‐scale CRISPR Knock‐out Screen in Chronic Myeloid Leukemia Identifies Novel Drug Resistance Mechanisms along with Intrinsic Apoptosis and MAPK Signaling.” Cancer Medicine 9 (18): 6739–51. doi:10.1002/cam4.3231.